Inventor · disambiguated record
Peter Emig
Also filed as: EMIG PETER · EMIG PETER DR · EMIG PETER-PAUL
30 granted patents·8 pending applications·798 citations·filing 1975–2008
97Inventor score
Top patents by PatentIndex Score
38 records- 0195US7026310B2Heteroaryl derivatives and their use as medicamentsZENTARIS GMBH·Filed 2005·Granted Apr 11, 2006·39 cites·14 claims
- 0293US6638935B2Heteroary1 derivatives and their use as medicamentsZENTARIS AG·Filed 2001·Granted Oct 28, 2003·54 cites·48 claims
- 0392US7056912B2Heteroaryl derivatives and their use as medicamentsZENTARIS GMBH·Filed 2003·Granted Jun 6, 2006·41 cites·15 claims
- 0492US6936615B2Heteroaryl derivatives and their use as medicamentsZENTARIS GMBH·Filed 2003·Granted Aug 30, 2005·38 cites·14 claims
- 0592US6890926B2Heteroaryl derivatives and their use as medicamentsZENTARIS AG·Filed 2001·Granted May 10, 2005·39 cites·13 claims
- 0691US6232327B1Indolyl-3-glyoxylic acid derivatives having antitumor actionASTA MEDICA AG·Filed 1999·Granted May 15, 2001·78 cites·5 claims
- 0788US6706722B2Heteroaryl derivatives and their use as medicamentsZENTARIS AG·Filed 2001·Granted Mar 16, 2004·55 cites·10 claims
- 0887US6693119B2Indolyl-3-glyoxylic acid derivatives having therapeutically valuable propertiesBAXTER HEALTHCARE SA·Filed 2000·Granted Feb 17, 2004·28 cites·12 claims
- 0987US6008231AN-substituted indole-3 glyoxylamides having anti-asthmatic antiallergic and immunosuppressant/immuno-modulating actionASTA MEDICA AKTIENGESELLSCHGT·Filed 1997·Granted Dec 28, 1999·75 cites·11 claims
- 1086US6432987B2Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor actionZENTARIS AG·Filed 2000·Granted Aug 13, 2002·32 cites·10 claims
- 1186US5162346APharmaceutical composition comprising flupirtine and its use to combat muscular tensionASTA MEDICA AG·Filed 1991·Granted Nov 10, 1992·55 cites·2 claims
- 1281US5965582AN-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunemodulating effectASTA MEDICA AG·Filed 1995·Granted Oct 12, 1999·63 cites·17 claims
- 1380US4923858ASubstituted 3-(n-heterocyclic)-2,6-diaminopyridines and -n-oxidesASTA PHARMA AG·Filed 1989·Granted May 8, 1990·27 cites·3 claims
- 1478US5284861APharmaceutical composition comprising flupirtine and its use to combat Parkinson disordersASTA MEDICA AG·Filed 1992·Granted Feb 8, 1994·33 cites·2 claims
- 1576US7452910B2Indolyl-3-glyoxylic acid derivatives having therapeutically valuable propertiesZIOPHARM ONCOLOGY INC·Filed 2003·Granted Nov 18, 2008·7 cites·13 claims
- 1676US6344467B1N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating actionASTA MEDICA AG·Filed 1999·Granted Feb 5, 2002·31 cites·10 claims
- 1774US5521178ACombination medication containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependenceASTA MEDICA AG·Filed 1993·Granted May 28, 1996·30 cites·3 claims
- 1874US4673666A2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate and pharmaceutical preparations containing itDEGUSSA·Filed 1985·Granted Jun 16, 1987·17 cites·18 claims
- 1973US7579365B2Indolyl-3-glyoxylic acid derivatives having antitumor actionZIOPHARM ONCOLOGY INC·Filed 2002·Granted Aug 25, 2009·5 cites·13 claims
- 2072US5942493ALH-RH antagonists having improved actionASTA MEDICA AG·Filed 1998·Granted Aug 24, 1999·19 cites·16 claims
- 2171US6919344B2N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating actionASTA MEDICA AG·Filed 2003·Granted Jul 19, 2005·4 cites·10 claims
- 2268US7365081B2Indole derivatives and their use as medicamentsAETERNA ZENTARIS GMBH·Filed 2001·Granted Apr 29, 2008·4 cites·9 claims
- 2365US4785110AProcess for the production of 2-amino-3-nitro-6-(4-fluorobenzylamino)-pyridineDEGUSSA·Filed 1986·Granted Nov 15, 1988·7 cites·7 claims
- 2462US2008027110A1Indolyl-3-glyoxylic acid derivatives having antitumor actionASTA MEDICA AG·Filed 2007·Application pending·0 cites
- 2561US8008324B2Indole derivatives and their use as medicamentAETERNA ZENTARIS GMBH·Filed 2008·Granted Aug 30, 2011·0 cites·11 claims
- 2659US7989453B2Indole derivatives and their use as medicamentAETERNA ZENTARIS GMBH·Filed 2007·Granted Aug 2, 2011·0 cites·2 claims
- 2758US2005245523A1Heteroaryl derivatives and their use as medicamentsZENTARIS GMBH·Filed 2005·Application pending·0 cites
- 2855US2008057124A1Indolyl-3-glyoxylic acid derivatives having therapeutically valuable propertiesNICKEL BERND·Filed 2007·Application pending·0 cites
- 2950US4738983AEthylenediamine and guanidine-derivativesDEGUSSA·Filed 1983·Granted Apr 19, 1988·2 cites·19 claims
- 3050US2002161025A1N-substituted indole-3glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating actionFiled 2002·Application pending·0 cites
- 3150US2003023093A1United states patent officeASTA MEDICA AG·Filed 2001·Application pending·0 cites
- 3249US5959115AProcess for the preparation of pure flupirtine maleate and its A modificationASTA MEDICA AG·Filed 1998·Granted Sep 28, 1999·10 cites·11 claims
- 3348US4851420A2,6-diamino-3-halobenzylpyridines and processes for their manufacture as well as their use in pharmaceuticalsASTA PHARMA AG·Filed 1987·Granted Jul 25, 1989·4 cites·18 claims
- 3443US2005009809A1Acridine derivatives and their use as medicamentsFiled 2004·Application pending·0 cites
- 3541US2004110756A1New anthracene derivatives and their use as pharmaceutical preparationsFiled 2003·Application pending·0 cites
- 3639US2004097734A1Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncosesFiled 2003·Application pending·0 cites
- 3736US4065501ABasic enol ether and acid addition salts thereofASTA WERKE AG CHEM FAB·Filed 1975·Granted Dec 27, 1977·1 cites·4 claims
- 3827US4124716AProcess for the treatment of spasmodic conditions in humansASTA WERKE AG CHEM FAB·Filed 1977·Granted Nov 7, 1978·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Peter Emig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →